Among emergent co-morbidities in the era of combination antiretroviral therapy (cART), bone complications such as osteonecrosis or osteoporosis are estimated to be more frequent in HIV infected treated patients than in the general population , , Many traditional [1 2 ] determinants such as smoking, alcohol consumption, low body mass index, sedentary lifestyle, digestive, renal and endocrine disorders can be identified in this population, while the role of HIV infection and antiretroviral treatment remains controversial ,
. As regards to [1 3 -6 ] the prevalence of usual risk factors in HIV-infected patients, incidence rate of bone fractures in those patients could increase over time . [7 ] However, there are little available data to quantify the risk in this population of patients. Our study estimated the incidence of bone fractures over a follow-up of 10 years in a national cohort of HIV1-infected patients on cART, described the type of fractures, and assessed potential determinants.
A total of 1,281 HIV1-infected adults were included into the ANRS CO8 APROCO-COPILOTE cohort when they were first prescribed a cART including a protease inhibitor, in 47 French centres between March 1997 and June 1999. Follow-up visits were performed one and four months after inclusion, then every four months. At each visit, a clinical examination and laboratory tests were performed; alcohol and tobacco consumption was assessed by a self-questionnaire administered to the patient. Severe and serious adverse events (SAE) were prospectively reported to the coordinating centre and reviewed by an Events Validation Committee . [8 ] All grade 3 or 4 fractures, i.e. leading to severe or complete limitation of activity and/or to patient s hospitalization during follow-up, ' were included into the analysis. Incidence density was estimated by dividing the number of patients who underwent a first bone fracture by the period at risk for all included patients expressed in patient-years. Potential risk factors for fracture were assessed using a Poisson : 2.0 to 4.6) ( ). In most cases (81 ), an acute traumatism (eg, fall, mugging, skiing or other accident, blow) was reported as In the multivariate analysis, the incidence rate of 3 3 bone fracture was 2.9-fold (95 CI: 1.3 6.5) higher in patients with excessive alcohol consumption and 3.6-fold (95 CI: 1.6 8.1) higher
in HCV co-infected patients than in others.
Incidence rate of bone fractures estimated in our study population is in the same range as the one reported in the general population in
Europe for the same age group, i.e 5 to 10 for 1,000 PY . However, we acknowledge that our estimation might be slightly [9 ] underestimated since only serious and severe adverse events were reported and monitored in our cohort and some fractures may have been treated on an outpatient basis.
Due to variable treatment exposure and frequent treatment modifications, we could not assess the role of a specific antiretroviral class or drug. In the context of a low number of fractures observed during this long follow-up, this study showed no association between specific markers of HIV disease (i.e HIV RNA, CD4 cell count, clinical stage or antiretroviral treatment) and the rate of bone fractures among our population. Alcohol consumption is a traditional determinant as it is known to increase both osteoporosis and risky behaviours and is, especially, higher in HCV/HIV-coinfected patients. Other studies have suggested that fractures and osteoporosis are more frequent in patients with chronic liver disease than in others, since patients with cirrhosis experience a decreased bone mass . This decreased bone [10 ] density might be due, in part, to vitamin D deficiency linked to cholestasis and/or hypogonadism.
Investigations in this field are to be carried on in a much larger number of patients and over extended follow-up periods. Although there is a lack of studies of specific drug treatment for prevention of bone fractures in HIV-infected patients, current HIV guidelines recommend the same preventive measures as in the general population, stressing the importance of non medicinal preventive measures.
Meanwhile, specific information, monitoring of HCV/HIV-coinfected patients and active promotion of alcohol cessation programs in HIV-infected patients are to be recommended for the prevention of bone fractures.
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